Polatuzumab vedotin 140mg powder for solution for infusion vials

in short Polatuzumab vedotin 140mg inf vials

SNOMED code
38235111000001104
Active compound
Polatuzumab vedotin
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Polatuzumab vedotin — 140 mg based on ingredient substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd)

in short Polivy 140mg pdr for concentrate for inf vials

Polivy 140mg powder for concentrate for solution for infusion vials

SNOMED code
38221511000001107
Supplier
Roche Products Ltd
Licensed as
Medicines - MHRA/EMA
EMA (European Medicines Agency) Monitoring
Yes, black triangle marked
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Polivy 140mg powder for concentrate for solution for infusion vials (Roche Products Ltd) 1 vial
38221611000001106   ref. pack
💯 Available

Legal category: POM
07613326024082

End: 7613326024082
NHS Indicative Price
£11,060
• Hospital
  • • Prescription Charges

Reference packs

Polatuzumab vedotin 140mg powder for solution for infusion vials 1 vial
SNOMED code
38221411000001108
Quantity and unit
1 vial
Packs